EUVIMEDEUVIMED entdecken
Crossref

Acrylamide Bioisosterism: Alkenyl Aromatic Heterocycles as Reactivity-Tunable Warheads for Covalent BTK Inhibitors

Yang Li, Siyu Fu, Jun Yang, Wentao Tang, Jifa Zhang iD, Wuyu Mao iD, Liang Ouyang iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c03212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Yang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Targeted Tracer Research and Development Laboratory, Institute of Res…. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Protein Kinase Inhibitors, Antineoplastic Agents, Acrylamide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cysteine-targeted covalent inhibitors have traditionally used a few electrophilic warheads, with Michael acceptors being the most common. However, their stability and selectivity in physiological conditions require enhancement. Inspired by the principles of bioisosterism, we have developed an innovative class of tunable electrophilic warheads by substituting the conventional acrylamide moiety in covalent inhibitors with alkenyl aromatic heterocycles. This approach aimed to enhance selectivity and reactivity. We synthesized a library of these warheads and integrated them into the BTK inhibitor ibrutinib. The resulting compounds showed strong and selective BTK inhibition, effectively blocking B-cell receptor signaling and cancer cell growth. Key derivatives specifically bound to the Cys481 residue of BTK, as confirmed by mass spectrometry and cellular tests. A lead compound demonstrated good pharmacokinetics and significant antitumor effects in a mouse model, highlighting this bioisosteric strategy as a promising avenue for covalent drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseProtein Kinase InhibitorsAntineoplastic AgentsAcrylamideHeterocyclic CompoundsAnimalsHumansBioisosterismMicePiperidinesStructure-Activity RelationshipCell Line, TumorPyrimidinesPyrazolesAdenineCell Proliferation

Substanzen

Agammaglobulinaemia Tyrosine KinaseProtein Kinase InhibitorsPiperidinesAntineoplastic AgentsAcrylamideibrutinibBTK protein, humanPyrimidinesPyrazolesAdenine

Autor:innen und Institutionen

  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Targeted Tracer Research and Development Laboratory, Institute of Respiratory, Laboratory of Neuro-System and Multimorbidity, Health Fronti…
  • School of Pharmacy, Key Laboratory of Sichuan Province for Specific Structure of Small Molecule Drugs, Chengdu Medical College, Chengdu, Sichuan 610500, China.

ORCID-Profile: Jifa Zhang, Wuyu Mao, Liang Ouyang

Förderung

  • Science and Technology Department of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Fu, S., Yang, J., Tang, W., Zhang, J., Mao, W., & Ouyang, L. (2026). Acrylamide Bioisosterism: Alkenyl Aromatic Heterocycles as Reactivity-Tunable Warheads for Covalent BTK Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03212

Vancouver

Li Y, Fu S, Yang J, Tang W, Zhang J, Mao W, et al. Acrylamide Bioisosterism: Alkenyl Aromatic Heterocycles as Reactivity-Tunable Warheads for Covalent BTK Inhibitors. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03212

BibTeX
@article{Li2026,
  author = {Li, Yang and Fu, Siyu and Yang, Jun and Tang, Wentao and Zhang, Jifa and Mao, Wuyu and Ouyang, Liang},
  title = {Acrylamide Bioisosterism: Alkenyl Aromatic Heterocycles as Reactivity-Tunable Warheads for Covalent BTK Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c03212}
}
Kostenlos starten →